Brain aging comes with chronic inflammation, and microglia play a key role in it. These cells stop carrying out their protective functions and begin constantly releasing inflammatory molecules. Nearby in the archive are studies on cellular senescence, epigenetics and stress responses, but they look at either individual aspects or other cell types. This paper fills the gap by comparing two different sources of stress in the same human microglial model.
The researchers used the human microglial cell line HMC3. Genotoxic stress was induced with doxorubicin at 50 nM for 48 hours, and metabolic stress was created by adding 200 mM glucose for 3 days. To control for the osmotic effect, mannitol was used at the same concentration. They assessed cell morphology, beta-galactosidase activity, DNA damage via γH2AX foci, protein and mRNA levels of key pathways, mitochondrial mass and the expression of inflammatory cytokines.
Both stresses caused cells and nuclei to enlarge, reduced metabolic activity and produced markers of aging. Genotoxic stress activated p53-p21 more strongly and gave a uniform pro-inflammatory response with IL6, IL8, CCL2-CCL5. Metabolic stress additionally switched on p16, changed the localization of p21 in the nucleus and produced a more selective cytokine profile with elevated IFNG and CCL3-CCL5, but without CCL2. Under genotoxic stress NRF2 and TFAM fell, whereas under metabolic stress they rose, yet without an effective antioxidant response. Apoptosis was not triggered in either case, which points to the survival of dysfunctional cells.
The work shows that microglial aging is not a single program but depends on the nature of the stressor. This sets it apart from neighboring studies, which often focus on one type of exposure or use animal models. Here, for the first time, two pathways have been directly compared in human microglia, revealing differences in cell cycle regulation, mitochondria and the inflammatory secretome.
Looking ahead, one could test how these different aging states affect neurons and other brain cells in co-culture. It is also important to study whether such differences persist in primary microglia and in in vivo models. A separate question is the reversibility of these states under the action of senolytics.
The results could help in developing therapies for Alzheimer's disease and other age-related neurodegenerative conditions in which microglia play a pathological role. They are also useful for research on metabolic disorders of the brain, for example in diabetes.
The immediate steps include validation in primary human microglia and in animal models, as well as transcriptome and proteome analysis for a more complete description of the aging programs.
In the neuroscience of aging, one question remains unresolved: why microglia in the brains of elderly people are not eliminated but instead accumulate in a dysfunctional state. This work addresses that problem directly, showing mechanisms of resistance to apoptosis and differences in inflammatory profiles depending on the stressor.
Doxorubicin, used here to damage DNA, was originally an antitumor antibiotic that itself induces cellular senescence. And the glucose concentration of 200 mM is 36 times higher than the normal level in human blood, which highlights how extreme the metabolic stress in the model is.
Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.